Crestor is a prescription pill that contains the active ingredient rosuvastatin, a member of the statin class of cholesterol-lowering medicines. It is marketed by AstraZeneca and is available in strengths of 5 mg, 10 mg, and 20 mg. In Hong Kong the drug is regulated by the Department of Health and requires a physician’s prescription. Rosuvastatin works by reducing the amount of low-density lipoprotein cholesterol (LDL-C) in the bloodstream, helping lower the risk of cardiovascular events.
Rosuvastatin inhibits the enzyme HMG-CoA reductase, which plays a central role in the liver’s production of cholesterol. By blocking this enzyme, the drug reduces the synthesis of cholesterol and up-regulates LDL receptors on liver cells. More receptors mean more LDL-C is cleared from the blood, leading to lower total and LDL cholesterol levels. The effect usually begins within a few days, reaches its peak at about two weeks, and sustains as long as the medication is taken.
These indications are approved by Hong Kong’s health authorities and are supported by large clinical trials that demonstrated reductions in major cardiovascular events when rosuvastatin is used as part of a comprehensive risk-reduction strategy.
Off-label use refers to applications that have not received formal regulatory approval. Some clinicians have explored rosuvastatin for:
Disclaimer: Off-label use requires medical supervision and an individualized risk-benefit assessment.
Patients with these conditions should discuss alternatives with their healthcare provider.
These effects are usually mild and transient. If they persist, patients should seek medical advice.
Any signs of muscle breakdown or liver injury warrant immediate medical evaluation.
Major:
Strong CYP2C9 inhibitors (e.g., fluconazole, itraconazole) can increase rosuvastatin exposure.
Cyclosporine markedly raises rosuvastatin levels; concurrent use is generally avoided.
Moderate:
Fibrates (gemfibrozil) and high-dose niacin increase the risk of myopathy.
Anticoagulants (warfarin) may require closer INR monitoring.
Patients should provide a full medication list-including over-the-counter products and herbal supplements-to their prescriber.
Standard dosing:
Begin with 5 mg once daily.
If LDL-C goals are not achieved after 4-12 weeks, the dose may be increased to 10 mg; the maximum approved dose is 20 mg once daily.
Renal adjustment:
For creatinine clearance < 30 mL/min, start at 5 mg and do not exceed 10 mg daily.
Administration:
Swallow the tablet whole with a glass of water.
Can be taken at any time of day, with or without food.
Missed dose:
Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.
Overdose:
Symptoms may include severe muscle pain, weakness, or liver dysfunction. Seek emergency medical care; treatment is mainly supportive.
Discontinuation:
No tapering is required, but lipid levels should be re-checked after stopping therapy, and patients should be monitored for rebound cholesterol elevation.
Regular follow-up appointments allow the clinician to assess efficacy, adjust dosing, and detect adverse effects early.
This article provides educational information about Crestor and is not a substitute for professional medical advice. Treatment decisions, including the use of rosuvastatin for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, Crestor can be taken during travel, but keep the medication in its original labeled container, carry it in your hand luggage, and have a copy of the prescription if you are traveling to countries with strict drug import rules. Avoid exposing the pills to extreme temperatures, such as leaving them in a hot car.
Crestor tablets are film-coated, round, and come in three colors corresponding to their strengths: 5 mg (white), 10 mg (light pink), and 20 mg (light red). Each tablet is imprinted with “Crestor” and the dosage amount for easy identification.
Statins, including rosuvastatin, are not prohibited substances in standard workplace or athletic drug-testing panels. They are not typically screened for, but it is prudent to disclose any prescription medications if asked by a testing authority.
Rosuvastatin has a longer plasma half-life and a higher potency per milligram, allowing effective LDL-C reduction at lower doses. It also demonstrates minimal metabolism by CYP3A4, reducing the likelihood of certain drug-drug interactions compared with atorvastatin.
Crestor tablets are designed for whole-tablet ingestion. Splitting or crushing may alter the drug’s release characteristics and affect absorption, potentially reducing efficacy or increasing side-effect risk. Always swallow the tablet whole unless directed otherwise by a pharmacist.
Rosuvastatin is contraindicated in active, clinically significant liver disease. In cases of mild, stable hepatic enzyme elevations, a healthcare provider may monitor liver function closely before deciding on therapy, but routine use is generally discouraged.
If a dose is missed on a Saturday, take the missed dose as soon as you remember unless it is already close to the next scheduled dose (e.g., Sunday night). In that case, skip the missed dose and resume the regular once-daily schedule; do not double-dose.
Significant reductions in LDL-C are typically observed within 2-4 weeks of consistent daily dosing, with the full effect usually evident by 8-12 weeks. Lipid panels are commonly repeated at these intervals to assess response.
Yes, after the expiry of Crestor’s patent, several manufacturers have introduced generic rosuvastatin tablets that contain the same active ingredient, strength, and dosage form. Generic options are regulated by the Hong Kong Department of Health and must meet the same quality standards as the brand product.
Rosuvastatin is eliminated primarily through the kidneys. Impaired renal function can increase drug exposure, raising the risk of muscle-related side effects. Periodic assessment of creatinine clearance helps ensure the prescribed dose remains safe for the patient’s kidney health.
